ORG Wealth Partners
HAE icon

ORG Wealth Partners’s Haemonetics HAE Stock Holding History

ORG Wealth Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$421 Buy
+4
New +$372 ﹤0.01% 2128

Other funds holding HAE

Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
River Road Asset Management
River Road Asset Management Louisville, Kentucky $8.42B AUM 5.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

ORG Wealth Partners's HAE Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Haemonetics (HAE) in Q3 2026: 4 shares worth $421. The stake represents ﹤0.01% of the portfolio and ranks #2128 among its holdings.

243 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • ORG Wealth Partners held 4 shares of Haemonetics worth $421 as of Q3 2026.
  • Haemonetics was a new ORG Wealth Partners position in Q3 2026.
  • Haemonetics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2128 holding.
  • 243 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.